Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Jun 15, 2023
- Accession no.
- 0001209191-23-037611
- Filed
- Jun 15, 2023
- Trade date
- Jun 13-15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $295.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | MOption exerciseAcquired | +5,628 | $0.61 | +$3,433.08 | 533,609 | Direct | |
| Jun 13, 2023 | Common Stock | SSaleDisposed | −5,628 | $16.01F2 | −$90,104.28 | 527,981 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseAcquired | +120 | $0.61 | +$73.2 | 528,101 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −120 | $16.45 | −$1,974 | 527,981 | Direct | |
| Jun 15, 2023 | Common Stock | MOption exerciseAcquired | +12,592 | $0.61 | +$7,681.12 | 540,573 | Direct | |
| Jun 15, 2023 | Common Stock | SSaleDisposed | −12,592 | $16.15F3 | −$203,360.8 | 527,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | MOption exerciseDisposed | −5,628 | $0.00 | $0 | 241,774 | Direct | |
| Jun 14, 2023 | Common Stock | MOption exerciseDisposed | −120 | $0.00 | $0 | 241,654 | Direct | |
| Jun 15, 2023 | Common Stock | MOption exerciseDisposed | −12,592 | $0.00 | $0 | 229,062 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.38. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.64. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.